140 related articles for article (PubMed ID: 19224213)
21. Clinical pharmacokinetics of paclitaxel liposome with a new route of administration in human based on the analysis with ultra performance liquid chromatography.
Wang X; Zheng H; Zhu Z; Wei Y; Chen L
J Pharm Sci; 2010 Nov; 99(11):4746-52. PubMed ID: 20845471
[TBL] [Abstract][Full Text] [Related]
22. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC
Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107
[TBL] [Abstract][Full Text] [Related]
23. Effects of Taxol on ascites cytology from a patient with fallopian tube carcinoma: report of a case with ultrastructural studies.
Kobayashi TK; Moritani S; Bamba M; Fujimoto Y; Urabe M; Kaneko C
Diagn Cytopathol; 2002 Aug; 27(2):132-4. PubMed ID: 12203886
[No Abstract] [Full Text] [Related]
24. Morphologic changes in ovarian carcinoma after neoadjuvant chemotherapy: report of a case showing extensive clear cell changes mimicking clear cell carcinoma.
Chew I; Soslow RA; Park KJ
Int J Gynecol Pathol; 2009 Sep; 28(5):442-6. PubMed ID: 19696613
[TBL] [Abstract][Full Text] [Related]
25. Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with Paclitaxel (Taxol) in a patient with metastatic ovarian carcinoma.
Schrader C; Keussen C; Bewig B; von Freier A; Lins M
Eur J Med Res; 2005 Nov; 10(11):498-501. PubMed ID: 16354605
[TBL] [Abstract][Full Text] [Related]
26. Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review.
Mantovani G; Gramignano G; Mais V; Melis GB; Parodo G; Carrucciu GM
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):238-9. PubMed ID: 16698170
[No Abstract] [Full Text] [Related]
27. Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer.
Yahata T; Nishikawa N; Aoki Y; Tanaka K
Gynecol Oncol; 2006 Nov; 103(2):752-4. PubMed ID: 16857250
[TBL] [Abstract][Full Text] [Related]
28. [Reinduction of paclitaxel therapy after a successfully treated hypersensitivity reaction].
Lehoczky O; Bagaméri A; Pulay T
Orv Hetil; 2002 Sep; 143(38):2189-91. PubMed ID: 12395475
[TBL] [Abstract][Full Text] [Related]
29. Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer.
Hunz M; Jetter A; Warm M; Pantke E; Tuscher M; Hempel G; Jaehde U; Untch M; Kurbacher C; Fuhr U
Clin Pharmacol Ther; 2007 May; 81(5):659-68. PubMed ID: 17301739
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of etoposide after intrathoracic instillation to lung cancer patients with pleural effusion.
Wada I; Yokouchi M; Saitoh H; Takada M; Nakabayashi T; Mino K; Honma T; Takeda T; Hirano K
Int J Clin Pharmacol Ther; 1999 May; 37(5):254-9. PubMed ID: 10363625
[TBL] [Abstract][Full Text] [Related]
32. [A case of intraperitoneal paclitaxel administration in a gastric cancer patient with severely impaired renal function].
Ohbu M; Maruyama M; Miyawaki Y; Tamura N; Koide A; Hasegawa K; Maruyama S; Takashima I; Ebuchi M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1745-7. PubMed ID: 16315928
[TBL] [Abstract][Full Text] [Related]
33. A case of advanced ovarian cancer upstaged on the bases of pleural washing cytology.
Kobayashi Y; Terauchi F; Nishi H; Fujitou A; Itou H; Isaka K
J Obstet Gynaecol Res; 2009 Jun; 35(3):588-92. PubMed ID: 19527407
[TBL] [Abstract][Full Text] [Related]
34. [A case of metastatic rectal cancer from serous adenocarcinoma of the ovary].
Miyake Y; Kato T; Oshima S; Iijima S; Kurokawa E; Okamoto Y; Kumazawa K; Chin R; Amemiya K; Adachi K; Kikkawa N
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2317-9. PubMed ID: 18079639
[TBL] [Abstract][Full Text] [Related]
35. A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions.
Perng RP; Wu MF; Lin SY; Chen YM; Lin JY; Whang-Peng J
Anticancer Drugs; 1997 Jul; 8(6):565-73. PubMed ID: 9300570
[TBL] [Abstract][Full Text] [Related]
36. [Studies on hypersensitivity and pharmacokinetics of paclitaxel microemulsion].
He L; Wang GL; Zhang Q
Yao Xue Xue Bao; 2003 Mar; 38(3):227-30. PubMed ID: 12830723
[TBL] [Abstract][Full Text] [Related]
37. Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer.
Teneriello MG; Tseng PC; Crozier M; Encarnacion C; Hancock K; Messing MJ; Boehm KA; Williams A; Asmar L
J Clin Oncol; 2009 Mar; 27(9):1426-31. PubMed ID: 19224848
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of ovarian cancer growth and implantation by paclitaxel after laparoscopic surgery in a mouse model.
Lee CL; Kay N
Am J Obstet Gynecol; 2006 Nov; 195(5):1278-81. PubMed ID: 17014818
[TBL] [Abstract][Full Text] [Related]
39. A unique case of serous psammocarcinoma of the ovary presenting with pleural effusion and manifesting psammoma body implants in the pleural cavity and pericardium.
Tiro AV; Talukdar R; Lewis MG
Gynecol Oncol; 2009 Jun; 113(3):402-4. PubMed ID: 19345402
[TBL] [Abstract][Full Text] [Related]
40. Cauda equina syndrome due to leptomeningeal carcinomatosis of the ovary.
Baek WS; Kubba SV
Gynecol Oncol; 2008 Dec; 111(3):544-5. PubMed ID: 18433846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
